(12S,22Z,32Z,52S,122Z,8S,11S,15R)-8-(4-aminobutyl)-15-benzyl-11-methyl-7,10,14-triaza-3(2,4)-oxazola-2,12(2,4)-dithiazola-1(2,1),5(1,2)-dipyrrolidinacyclohexadecaphane-4,6,9,13,16-pentaone | 1453168-13-2

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (12S,22Z,32Z,52S,122Z,8S,11S,15R)-8-(4-aminobutyl)-15-benzyl-11-methyl-7,10,14-triaza-3(2,4)-oxazola-2,12(2,4)-dithiazola-1(2,1),5(1,2)-dipyrrolidinacyclohexadecaphane-4,6,9,13,16-pentaone
• CAS: 1453168-13-2
• 化学式: C₃₇H₄₃N₉O₆S₂
• 分子量: 773.937
• InChiKey: SKXAPIBVULQYMU-JRIYTVSBSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.37
• 重原子数：
  54.0
• 可旋转键数：
  6.0
• 环数：
  7.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  205.75
• 氢给体数：
  4.0
• 氢受体数：
  12.0

反应信息

• 作为反应物：
  描述：

  (12S,22Z,32Z,52S,122Z,8S,11S,15R)-8-(4-aminobutyl)-15-benzyl-11-methyl-7,10,14-triaza-3(2,4)-oxazola-2,12(2,4)-dithiazola-1(2,1),5(1,2)-dipyrrolidinacyclohexadecaphane-4,6,9,13,16-pentaone 、 15-生物素-氨基-4,7,10,13-二氧杂壬酸N-羟基琥珀酰亚胺 在 N,N-二异丙基乙胺 作用下， 以 二氯甲烷 为溶剂， 反应 2.0h， 以39%的产率得到5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-N-[2-[2-[2-[2-[3-[4-[(6S,12R,19S,22S,25S)-12-benzyl-19-methyl-11,14,21,24,30-pentaoxo-33-oxa-4,17-dithia-10,13,20,23,29,34,35,36-octazahexacyclo[29.2.1.12,5.115,18.06,10.025,29]hexatriaconta-1(34),2,5(36),15,18(35),31-hexaen-22-yl]butylamino]-3-oxopropoxy]ethoxy]ethoxy]ethoxy]ethyl]pentanamide
  参考文献：
  名称：

  Mechanistic Studies of Sanguinamide B Derivatives: A Unique Inhibitor of Eukaryotic Ribosomes

  摘要：

  Described are mechanistic studies of two Sanguinamide B (San B) derivatives. These compounds were identified as eukaryotic ribosomal inhibitors. Two biotinylated San B derivatives were synthesized and used to capture protein targets in a pull-down assay. LC/MS/MS analysis of the San B-captured targets identified several proteins that comprise eukaryotic ribosomal subunits. The translation inhibitory effect of San B was confirmed using an in vitro translation assay. Moreover, an evaluation of cell death mechanisms is reported.

  DOI：

  10.1021/ol401749p
• 作为产物：
  描述：

  乙基2-[(1S)-1-氨基乙基]-1,3-噻唑-4-羧酸酯 在 氢溴酸 、 双氧水 、 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholin-4-ium 、 O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate 、 溶剂黄146 、 苯甲醚 、 1-丙基磷酸酐 、 N,N-二异丙基乙胺 、 Methanaminium,N-[(dimethylamino)(3H-1,2,3-triazolo[4,5-b]pyridin-3-yloxy)methylene]-N-methyl-, hexafluorophosphate(1-) 、 三氟乙酸 、 lithium hydroxide 作用下， 以 乙醇 、 二氯甲烷 为溶剂， 反应 4.0h， 生成 (12S,22Z,32Z,52S,122Z,8S,11S,15R)-8-(4-aminobutyl)-15-benzyl-11-methyl-7,10,14-triaza-3(2,4)-oxazola-2,12(2,4)-dithiazola-1(2,1),5(1,2)-dipyrrolidinacyclohexadecaphane-4,6,9,13,16-pentaone
  参考文献：
  名称：

  Mechanistic Studies of Sanguinamide B Derivatives: A Unique Inhibitor of Eukaryotic Ribosomes

  摘要：

  Described are mechanistic studies of two Sanguinamide B (San B) derivatives. These compounds were identified as eukaryotic ribosomal inhibitors. Two biotinylated San B derivatives were synthesized and used to capture protein targets in a pull-down assay. LC/MS/MS analysis of the San B-captured targets identified several proteins that comprise eukaryotic ribosomal subunits. The translation inhibitory effect of San B was confirmed using an in vitro translation assay. Moreover, an evaluation of cell death mechanisms is reported.

  DOI：

  10.1021/ol401749p